Piscataway, NJ, June 7, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Eszopiclone Tablets, USP to its product line.
Eszopiclone Tablets, USP are indicated for the treatment of insomnia. Eszopiclone tablets has been shown to decrease sleep latency and improve sleep maintenance.
Eszopiclone Tablets, USP are available in 1, 2 and 3 mg strengths in both 30 and 100 count bottles.
To learn more about Eszopiclone Tablets, USP, please visit https://www.camberpharma.com/eszopiclone
